The Globe and Mail

BioNTech Highlights Late-Stage Oncology Pipeline and New Data Ahead of 2026 ASCO Meeting

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds An update from ...
The Globe and Mail

Legend Biotech to Showcase New CAR-T Data at ASCO 2026

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds Legend Biotech ...
manilatimes

2026 ASCO | Pivotal Data of InnoCare's Novel BCL2 Inhibitor Mesutoclax Released

BEIJING, May 22, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...
The Hamilton Spectator

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

SAN DIEGO, May 22, 2026 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, today announced translational data ...
manilatimes

Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation

REDWOOD CITY, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...
ascopubs.org

Systemic Treatment of Thyroid Cancer: ASCO Guideline

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600–Mutant Solid Tumors ASCO Guidelines provide ...
Joplin Globe

Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026

Flatiron Health today announced its presence at the American Society of Clinical Oncology (ASCO) Annual Meeting happening from May 29 - June 2, 2026, in Chicago, Illinois. Flatiron's high-quality real ...
The Caledonian Record

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

HONG KONG and FLORHAM PARK, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of ...
Targeted Oncology

The LBAs to Watch for at the 2026 ASCO Meeting

Izalontamab brengitecan achieved dual primary end point improvements in PFS and OS versus physician’s choice chemotherapy in previously treated locally advanced/metastatic TNBC, challenging later-line ...
The Caledonian Record

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

WAKE FOREST, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a specialist global Contract Research Organization (CRO) focused on accelerating clinical development for biotechnology companies, ...
Joplin Globe

Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), will present new data from nine approved and investigational medicines across more than 15 indications at the 2026 American Society ...